Live Breaking News & Updates on அமெரிக்கன் இதயம் சங்கம் ப்ரிஸிஶந் மருந்து நடைமேடை

Stay updated with breaking news from அமெரிக்கன் இதயம் சங்கம் ப்ரிஸிஶந் மருந்து நடைமேடை. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Precision Medicine Platform accelerates data sharing and collaboration in scientific research


American Heart Association
DALLAS and SANTA CLARA, Calif. –
Efficient, rapid data management and analysis are critical to finding effective health care solutions aimed at improving patient outcomes. A new alliance between the American Heart Association’s Precision Medicine Platform and Hitachi Vantara, the digital infrastructure, data management, and digital solutions subsidiary of Hitachi, Ltd. (TSE: 6501), will make the Association’s Precision Medicine Platform even more accessible to healthcare organizations for fast, efficient supercomputing data analysis research, even from a laptop computer.
The Precision Medicine Platform is a cloud-based digital solution with secure, private workspaces equipped for data management and analysis, including tools for machine learning and artificial intelligence. With flexible choices for software and ready-to-run data analysis tools, the Precision Medicine Platform is ready to run at a fraction of the cost of traditional da ....

United States , Jennifer Hall , Paul Watson , Institute For Precision Cardiovascular Medicine , American Heart Association , American Heart Association Precision Medicine Platform , Hitachi Ltd , Association Precision Medicine Platform , Hitachi Vantara , Healthcare Life Sciences , Precision Medicine Platform , Precision Cardiovascular Medicine , American Heart , Life Sciences , Precision Medicine , ஒன்றுபட்டது மாநிலங்களில் , ஜெனிபர் மண்டபம் , பால் வாட்சன் , நிறுவனம் க்கு ப்ரிஸிஶந் இருதய மருந்து , அமெரிக்கன் இதயம் சங்கம் , அமெரிக்கன் இதயம் சங்கம் ப்ரிஸிஶந் மருந்து நடைமேடை , ஹிட்டாச்சி லிமிடெட் , ஹிட்டாச்சி வந்தாரா , சுகாதாரம் வாழ்க்கை அறிவியல் , ப்ரிஸிஶந் மருந்து நடைமேடை , ப்ரிஸிஶந் இருதய மருந்து ,

AI assigns equal weighting for coffee's role in reducing heart failure risk


A study that uses Artificial Intelligence (AI) to emphasise coffee’s importance in reducing Heart Failure (HF) risk is said to hold much promise in explaining pathways connecting dietary choices to the condition.
The study draws on the power of machine learning to rank coffee consumption as important as age, blood pressure, heart rate, and weight in links to HF risk, unintentionally becoming the research focus.
“The association between caffeine and heart failure risk reduction was surprising,”​ states Dr David Kao, senior study author, assistant professor of cardiology at the University of Colorado.
“Coffee and caffeine are often considered by the general population to be bad for the heart because people associate them with palpitations, high blood pressure, etc. The consistent relationship between increasing caffeine consumption and decreasing heart failure risk turns that assumption on its head.”​ ....

United States , David Kao , American Heart Association Precision Medicine Platform , Professor At Tufts University School Of Medicine , University Of Colorado , Cardiovascular Health Study , Cardiovascular Health , Pennsylvania State University , American Heart Association , Precision Medicine Platform , Framingham Heart , Atherosclerosis Risk , Communities Study , Amanda Vest , Assistant Professor , Tufts University School , Penny Kris Etherton , Pennsylvania State , Heart Failure , ஒன்றுபட்டது மாநிலங்களில் , டேவிட் காவ் , அமெரிக்கன் இதயம் சங்கம் ப்ரிஸிஶந் மருந்து நடைமேடை , பல்கலைக்கழகம் ஆஃப் கொலராடோ , இருதய ஆரோக்கியம் படிப்பு , இருதய ஆரோக்கியம் , பென்சில்வேனியா நிலை பல்கலைக்கழகம் ,

Study: Drinking More Coffee Associated with Decreased Heart Failure Risk